nmda receptor blockers (Tocris)

Tocris is a verified supplier

Tocris manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Tocris nmda receptor blockers

Electrophysiological measurements of <t>NMDA-dependent</t> currents in iPSC-derived neurons in BPM and NMM conditions after 60 days in culture. ( A ) AMPA and NMDA mediated components of synaptic currents were isolated by adding LY303070 , which selectively blocks AMPA-mediated EPSCs. Subsequent application <t>of</t> <t>APV</t> fully abolished spontaneous synaptic transmission. ( B ) Representative membrane current upon addition of 100 μM NMDA with 10 μM Glycine in neurons cultured in BPM and NMM. The superimposed grey line illustrates a single exponential fitting the desensitization process with the indicated τ. ( C , D ) Quantification of the NMDA-induced current amplitudes normalized respect to cell capacitance (C, n = 17 for BPM, n = 7 for NMM; p = 0.2094, Mann–Whitney test) and desensitization τ (D, n = 16 for BPM, n = 6 for NMM, p = 0.1775, Mann–Whitney test). ( E ) Same as B), upon addition of 1 μM Ro 25–6981 for inhibiting GluN2B containing receptors. Superimposed grey traces are the responses without blocker added. ( F ) Percentage of Ro 25–6981 inhibition respect to NMDA-induced current ( n = 15 for BPM, n = 5 for NMM, * p < 0.05, Two-tailed Student’s t test. Expression values are mean ± SEM).

Nmda Receptor Blockers, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 2093 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmda+receptor+blockers/NMDA/pmc13013697-258-0-4
Average 96 stars, based on 2093 article reviews

nmda receptor blockers - by Bioz Stars, 2026-10

96/100 stars

Images

1) Product Images from "GluN2A-mediated currents and calcium signal in human iPSC-derived neurons"

Article Title: GluN2A-mediated currents and calcium signal in human iPSC-derived neurons

Journal: Scientific Reports

doi: 10.1038/s41598-026-38482-y

Electrophysiological measurements of NMDA-dependent currents in iPSC-derived neurons in BPM and NMM conditions after 60 days in culture. ( A ) AMPA and NMDA mediated components of synaptic currents were isolated by adding LY303070 , which selectively blocks AMPA-mediated EPSCs. Subsequent application of APV fully abolished spontaneous synaptic transmission. ( B ) Representative membrane current upon addition of 100 μM NMDA with 10 μM Glycine in neurons cultured in BPM and NMM. The superimposed grey line illustrates a single exponential fitting the desensitization process with the indicated τ. ( C , D ) Quantification of the NMDA-induced current amplitudes normalized respect to cell capacitance (C, n = 17 for BPM, n = 7 for NMM; p = 0.2094, Mann–Whitney test) and desensitization τ (D, n = 16 for BPM, n = 6 for NMM, p = 0.1775, Mann–Whitney test). ( E ) Same as B), upon addition of 1 μM Ro 25–6981 for inhibiting GluN2B containing receptors. Superimposed grey traces are the responses without blocker added. ( F ) Percentage of Ro 25–6981 inhibition respect to NMDA-induced current ( n = 15 for BPM, n = 5 for NMM, * p < 0.05, Two-tailed Student’s t test. Expression values are mean ± SEM).

Figure Legend Snippet: Electrophysiological measurements of NMDA-dependent currents in iPSC-derived neurons in BPM and NMM conditions after 60 days in culture. ( A ) AMPA and NMDA mediated components of synaptic currents were isolated by adding LY303070 , which selectively blocks AMPA-mediated EPSCs. Subsequent application of APV fully abolished spontaneous synaptic transmission. ( B ) Representative membrane current upon addition of 100 μM NMDA with 10 μM Glycine in neurons cultured in BPM and NMM. The superimposed grey line illustrates a single exponential fitting the desensitization process with the indicated τ. ( C , D ) Quantification of the NMDA-induced current amplitudes normalized respect to cell capacitance (C, n = 17 for BPM, n = 7 for NMM; p = 0.2094, Mann–Whitney test) and desensitization τ (D, n = 16 for BPM, n = 6 for NMM, p = 0.1775, Mann–Whitney test). ( E ) Same as B), upon addition of 1 μM Ro 25–6981 for inhibiting GluN2B containing receptors. Superimposed grey traces are the responses without blocker added. ( F ) Percentage of Ro 25–6981 inhibition respect to NMDA-induced current ( n = 15 for BPM, n = 5 for NMM, * p < 0.05, Two-tailed Student’s t test. Expression values are mean ± SEM).

Techniques Used: Derivative Assay, Isolation, Transmission Assay, Membrane, Cell Culture, MANN-WHITNEY, Inhibition, Two Tailed Test, Expressing

Intracellular calcium changes in iPSC-derived neural cultures in BPM and NMM conditions after 60 days in culture. ( A ) Representative average traces of the Fura-2 signal in neural cells cultured in BPM and NMM at basal conditions, after perfusion of the agonist NMDA (without Mg 2+ ), the addition of either the NMDAR antagonist APV ( n = 52 for BPM, n = 11 for NMM) or the GluN2B inhibitor Ro 25–6981 ( n = 33 for BPM and n = 11 for NMM), and finally perfusion of KCl. The pictures at the right side illustrate the Ca 2+ signal by Fura-2 at different time points indicated by coloured dots on the trace. ( B ) Quantification of Fura-2 signal (F340/380) under no stimulation in neural cultures ( n = 7 for BPM, n = 9 for NMM). ( C ) Percentage of cells that respond to NMDA ( n = 399 for BPM, n = 837 for NMM; deviation of > 0.1 in the Fura-2 signal from the baseline, **** p < 0.0001; Fisher’s exact test). ( D ) Amplitude of Fura-2 signal induced by NMDA perfusion ( n = 268 for BPM, n = 98 for NMM; **** p < 0.0001; Mann–Whitney test). ( E ) Percentage of Fura-2 signal inhibition by APV respect to NMDA Fura-2 signal ( n = 152 for BPM, n = 41 for NMM). ( F ) Percentage of Fura-2 signal inhibition induced by Ro-6981 respect to NMDA Fura-2 signal ( n = 117 for BPM, n = 58 for NMM; *** p < 0.0002; Mann–Whitney test). ( G ) Heatmap extracted from the RNA-seq showing the 45 up (red)- and down (blue)-regulated genes in the GO cluster “Calcium signaling”. Expression values are mean ± interquartile range.

Figure Legend Snippet: Intracellular calcium changes in iPSC-derived neural cultures in BPM and NMM conditions after 60 days in culture. ( A ) Representative average traces of the Fura-2 signal in neural cells cultured in BPM and NMM at basal conditions, after perfusion of the agonist NMDA (without Mg 2+ ), the addition of either the NMDAR antagonist APV ( n = 52 for BPM, n = 11 for NMM) or the GluN2B inhibitor Ro 25–6981 ( n = 33 for BPM and n = 11 for NMM), and finally perfusion of KCl. The pictures at the right side illustrate the Ca 2+ signal by Fura-2 at different time points indicated by coloured dots on the trace. ( B ) Quantification of Fura-2 signal (F340/380) under no stimulation in neural cultures ( n = 7 for BPM, n = 9 for NMM). ( C ) Percentage of cells that respond to NMDA ( n = 399 for BPM, n = 837 for NMM; deviation of > 0.1 in the Fura-2 signal from the baseline, **** p < 0.0001; Fisher’s exact test). ( D ) Amplitude of Fura-2 signal induced by NMDA perfusion ( n = 268 for BPM, n = 98 for NMM; **** p < 0.0001; Mann–Whitney test). ( E ) Percentage of Fura-2 signal inhibition by APV respect to NMDA Fura-2 signal ( n = 152 for BPM, n = 41 for NMM). ( F ) Percentage of Fura-2 signal inhibition induced by Ro-6981 respect to NMDA Fura-2 signal ( n = 117 for BPM, n = 58 for NMM; *** p < 0.0002; Mann–Whitney test). ( G ) Heatmap extracted from the RNA-seq showing the 45 up (red)- and down (blue)-regulated genes in the GO cluster “Calcium signaling”. Expression values are mean ± interquartile range.

Techniques Used: Derivative Assay, Cell Culture, MANN-WHITNEY, Inhibition, RNA Sequencing, Expressing

Selection:

Article Title: The non-adrenergic imidazoline-1 receptor protein nischarin is a key regulator of astrocyte glutamate uptake
Article Snippet: .. To prevent these effects we therefore supplemented the aCSF with a selection of blockers, which were present throughout the experiment: TTX to block action potentials (150nM, Tocris), a GABA A receptor blocker (bicuculline 10 μM, Sigma), NMDA receptor blockers (D-AP5 50 μM, Tocris; (+)MK-801 10 μM, Sigma; 5,7-DCK 10 μM, Sigma), an AMPA and kainate receptor blocker (NBQX 10 μM, Sigma), and an inwardly rectifying potassium channel blocker (barium chloride 200 μM, Sigma) which does not affect glutamate transport ( ). .. A non-transported glial glutamate transporter blocker , TFB-TBOA (10 μM, Tocris) was also used in some experiments to block the glutamate transporter current evoked by D-aspartate.

Article Title: The non-adrenergic imidazoline-1 receptor protein nischarin is a key regulator of astrocyte glutamate uptake.
Article Snippet: .. To prevent these effects we therefore supplemented the aCSF with a selection of blockers, which were present throughout the experiment: TTX to block action potentials (150nM, Tocris), a GABAA receptor blocker (bicuculline 10 mM, Sigma), NMDA receptor blockers (D-AP5 50 mM, Tocris; (+)MK-801 10 mM, Sigma; 5,7-DCK 10 mM, Sigma), an AMPA and kainate receptor blocker (NBQX 10 mM, Sigma), and an inwardly rectifying potassium channel blocker (barium chloride 200 mM, Sigma) which does not affect glutamate transport (Barbour et al., 1991). .. A non-transported glial glutamate transporter blocker (Shimamoto et al., 2004), TFB-TBOA (10 mM, Tocris) was also used in some experiments to block the glutamate transporter current evoked by D-aspartate.

Article Title: The non-adrenergic imidazoline-1 receptor protein Nischarin is a key regulator of astrocyte glutamate uptake
Article Snippet: .. To prevent these effects we therefore supplemented the aCSF with a selection of blockers, which were present throughout the experiment: TTX to block action potentials (150nM, Tocris), a GABAA receptor blocker (bicuculline 10 μM, Sigma), NMDA receptor blockers (D-AP5 50 μM, Tocris; (+)MK-801 10 μM, Sigma; 5,7-DCK 10 μM, Sigma), an AMPA and kainate receptor blocker (NBQX 10 μM, Sigma), and an inwardly rectifying potassium channel blocker (barium chloride 200 μM, Sigma) which does not affect glutamate transport (Barbour et al., 1991). .. A non-transported glial glutamate transporter blocker (Shimamoto et al ., 2004), TFB-TBOA (10 μM, Tocris) was also used in some experiments to block the glutamate transporter current evoked by D-aspartate.

Blocking Assay:

other:

Article Title: Cell-type-specific integration of feedforward and feedback synaptic inputs in the posterior parietal cortex.
Article Snippet: After recovery, we applied a combination of AMPA- and NMDA receptor blockers – 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-fulfonamide (NBQX, 10 mM, Tocris) and 2-amino-5-phosphonopentanoic acid (AP5, 50 mM, Tocris), respectively – to confirm synaptic responses were indeed glutamatergic.

Review